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IN the course of a series of tests of iroii-containing compounds and iroli-
complexes for carcinogenicity, it was found that a preparation of rat-ferritin
induced notonly ahigh incidence ofsarcomata at the site ofrepeated subcutaneous
injection, but also testicular atrophy, Leydig-cell hyperplasia and benign Leydig-
cell tumours (Haddow, Dukes and Mitchley, 1961). The ferritin used in these
experiments was prepared by the precipitation of rat liver protein by a cadmium
salt, and contained cadmium as an essential part of its crystalline structure.
Since cadmium is known to cause testicular atrophy (Parizek and Zahor, 1956 ;
Meek, 1959 ; Kar and Das, 1960 ; Parizek, 1960) we decided to see whether the
effects of rat ferritin could be induced by iiijections of a cadmium salt alone.
Cadmium sulphate was the salt chosen for this purpose.
Recently, and at about the time the experiments to be described were being
completed, two reports of the carcinogenicity of cadmium appeared. Heath
et al. (1962) injected 20 hooded rats intramuscularly with cadmium powder sus-
pended in fowl serum, 10 ofthe rats receiving 28 mg. each and 10receiving 14 mg.
each. Altogether 15 of the 20 rats developed malignant tumours: rhabdomyo-
sarcomata and fibrosarcomata. Kazantzis (19.63) injected 10 Wistar rats (Chester
Beatty strain) subcutaneously at two sites with 25 mg. cadmium sulphide sus-
pended in physiological saline. Sarcomata developed in 6 of the animals within
12 months. Neither of these authors described testic-Lilar changes in their experi-
mental animals.
In this paper the induction of sarcomata at the site of subcutaneous injectiol-i
of
" rat-ferritin
" or cadmiumsulphate in rats is described and the failure to induce
similar tumours in mice bv injection of the same agents, reported. In an accom-
panying paper (Roe et al., 1964) the testicular and pituitary changes following the
injection of eadmi-Lun sulphate, or ferritin. are described and discussed.
MATERIALS AND ',,%IETHODS
Rats : Male albino rats of the Chester Beatty straiii were used. In the first
experiment courses of injection were begun when the rats were 3-4 weeks old
(80-100g.), and in the thirdexperiment whenthey were 6-7 weeks old (I70-200g.).
(Rats of this strain are exceptionally large.) The rats were housed in metal cages
in groups of 10, fed cubed Diet 86 on 2 days of each week and white bread plus
milk, cod liver oil, margarine, or marmite on the 5 other davs. Water was
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Mice: Random-bred Chester Beatty stock strain mice were used in Experi-
ments II and IV. All mice were vaccinated on the tail with sheep lymph as a
precaution against ectromelia. Injections were begun when the mice were 6 weeks
old (25-35 g.). (Mice of this strain are exceptionally large.) Mice were housed
in metal cages, 5 to a cage, fed Diet 41B and given water ad libitum.
Preparation of ferritin. The details of the preparation of ferritin are as
follows :-
Two kilograms of rat's liver were collected and homogenised with water and
heated to 80° C. to coagulate. The mass was then filtered through muslin and
subsequently through a Whatman No. 1 filter paper. A clear brown solution was
obtained.
To each 100 ml. ofthe above solution ammonium sulphate (A.R. grade) (30 g.)
was added and the suspension allowed to stand at 4° C. in a refrigerator overnight.
The resulting precipitate was collected by centrifugation. It was then dissolved
in water and filtered, cadmium sulphate solution (4-5 g. per 100 ml.) added, and
the whole kept at 4° C. in a refrigerator for 2 days. The resulting precipitate was
collected by centrifugation and dried in a desiccator. The dried crude ferritin
was re-crystallised by dissolving in ammonium sulphate solution (10%) to which
was added cadmium sulphate solution (4%o). After standing some time in the
cold the ferritin was collected and rapidly washed with a saturated solution of
potassium chloride.
The crystallisation of ferritin can be achieved by means of Zn, Cd, Ni or Co
salts. Cadmium sulphate is the salt most commonly chosen for this. It seems
necessary to have one of these elements present to form crystals. The cadmium
may be considered to serve two functions; the first, to co-ordinate the molecules
of ferritin into a definite lattice pattern; the second to decrease the solubility of
ferritin, thus favouring crystallisation. The cadmium content ofthere-crystallised
ferritin was reduced by washing with a saturated potassium chloride solution, but
some cadmium certainly remained in the final ferritin product used.
Chemicals. Crystalline cadmium sulphate with the formula Cd SO4.4H20 was
used, after a check had been made on its content ofcadmium and water ofcrystal-
lisation.
Observation of animals. Animals were examined regularly each week for the
presence of tumours at the site of injection. They were killed when they became
sick or developed rapidly growing injection-site tumours.
Post-mortem examination. All animals, whether killed because sick, or found
dead, were subjected to careful post mortem examination. Organs showing patho-
logical appearances were taken for histological examination.
Experiment I: Induction ofSarcomata at the Site of Subcutaneous Injection
of Cadmium-precipitated Rat-Ferritin (in Rats)
Twenty male rats, 3 weeks old, were injected subcutaneously in the right flank
with ferritin prepared as above: the initial dose was 20 mg. but this caused
severe ulceration at the injection site. A second dose of 20 mg. was given after
an interval of 46 days and since this also caused a severe local reaction it was
followed by eight doses of 2 mg. at weekly intervals, all given subcutaneously at
the same site.
After 15 months one rat developed a palpable tumour at the site of injectionCADMIUM NEOPLASIA 669
This proved to be a spindle ceR sarcoma (Fig. I and 2). The only other lesion
observed was atrophy of the seminiferous tubules in both testes. Fifteen of the
remaining 19 rats were kiRed at intervals during the next 12 months, 6 of them
with tumours at the site ofinjection. Material was taken for section from local
tumours, both testes and other tissues in which abnormahties were noticed post
mortem. Four rats in the series were
" found dead
" and too decomposed for
histological investigations. However, as no visible or palpable tumour was
present when these animals were examined during the 7 days preceding death,
it may be presumed that they did not develop injection-site tumours.
Table I shows the incidence and time ofappearance oftumours at theinjection
site. All seven injection-site tumours proved to be sarcomata. The testicular
lesions are considered in detail in the accompanying paper (Roe et al., 1964).
No neoplasms ofother organs were observed in this series of rats.
Experiment II : Failure ofRat-Ferritin whenInjected Subcutaneously
into Mice, to induce, Local Sarcomata
Ten male stockmice, aged about 6weeks, weregiven 3 subcutaneousinjections
into the right flank of 5 mg. rat ferritin at weekly intei-vals. Thereafter, because
of inflammation and ulceration at the injection site, the animals were left for 6
weeks without treatment and the amount given in subsequeiit injections was
reduced to 0-5 mg. A further 12 injections into the same flank of the reduced
amount were given at weekly intervals. Eight of the mice died before the 10th
month, one survived 13 months, and one almost 20 months. None developed
tumours at the site of injection (Table 1). One mouse developed generalised
mahgnant lymphoma after 6 months. This condition occurs not infrequently
in untreated raice of the strain used, and the occurrence of one case cannot be
attributed to treatment in thepresentexperiment. No otherneoplasms were seen
in any animal. At the time this experiment was undertaken thereappeared to be
no special reason for examining the testes at post mortem. Nevertheless, ifgross changes in them had been present in any ofthe 10 male mice it islikely thatthey would have been observed. In fact none were noted.
Experiment III : Indqtction ofSarcomata at the, Site ofSubcutaneous
Injection of Cadmium Sulphate, in Rats
Twenty male rats, 6-7 weeks old, were given injections of 0.5 mg. cadmium
sulphate in 1-0 ml. sterile distiRed water subcutaneously into the right flank
once weekly for 10 weeks. The total dose of metallic cadmium amounted to
2-0 mg. A group of 16 control male rats were kept under observation without
treatment.
After 101 months a tumour, which subsequently proved to be a spindle cell
sarcoma, arose at the injection site of one ofthe test group. By the 20th month
14 out of the 20 rats in the group had developed similar tumours (Fig. 3 and 4). Apart from tumour formation extensive calcification was sometimes seen at the
injection site. Fig. 5 iBustrates this finding in a rat which failed to develop a
tumour.
Testicularatrophy,Leydig-cell hyperplasiaandneoplasia,andpituitarychanges
were seeninmostofthecadmium-treatedrats(seeaccompanyingpaperfordetails-
Roe et al., 1964). No significant changes were observed in any other organ.
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Amongst the 16 untreated control rats the only neoplasm observed was a
parenchymal-cell hepatoma. This was in a 12 months old rat. The survival of
the control and treated rats was similar (Table 1).
Experiment IV : Failure to Induce, Sarcomata at the, Site, of
Subcutaneous Injection of Cadmium Sulphate, in Mice
Twenty male stock mice, 6-7 weeks old, were given eleven once-weekly injec-
tions of0.05 mg. cadmiumsulphate in 0.2 ml. sterile distiHed watersubcutaneously
into the right flank. The total dose of metallic cadmium amounted to 0-22 mg.
A similar group ofn-iiee was kept under observation without treatment.
No injection-site tumours were observed in the cadmium-treated group but
testicular atrophy, often with Leydig-cell hyperplasia, was present in almost all
these animals (Roe et al., 1964).
Generalised malignant lymphoma was observed in 4 of the cadmium-treated
mice (in animals dvine after 8, 13, 16 and 19months, respectively), and a locahsed
reticulosarcoma was seen in an animal killed during the 15th month. In the
untreated controls generalised malignant lymphoma was seen in 3 animals (9, 17,
and 19 months, respectively, from the beginning of the observation period, i.e.
when the mice were 7 weeks old). In addition, a mouse dying during the 8th
month had a parenchymal-ceR tumour of the liver, one dying during the 9th
month had a disseminated undifferentiated intra-abdominal adenocarcinoma of
uncertainorigin, and onedyingduring the 13th month had two small adenomatons
tumours ofthe lung.
DISCUSSION
A yield of 7 injection-site sarcomata in 20 rats injected with rat-ferritin after
an average latent interval of 21-6 months is indicative of quite definite carcino-
genicity oftheinjected material. On the otherhand, thenegative result obtained
in 10 miceinjected with a ratherhigher dose ofrat-ferritin (on abodyweightbasis)
is lessmeaningful, particularly because oftheir poor survival. After theseexperi-
ments with rat-ferritin were complete it remained uncertain whether theinjection-
site tumours, and the testicular changes and neoplasms (Roe et al., 1964) were
due, as seemedlikely, entirely to cadmium present in the ferritin or whether other
constituents of the ferritin contributed to the effects seen. This problem persists
since we have been unable so far to obtain a sample of ferritin which is free from
cadmium. On the other hand, we have obtained further information on the
carcinogenicity of cadmium in the absence of ferritin.
A total dose of 2-0 mg. Cd as CdSO4.4H20 gave rise to 14 injection-site
sarcomata in 20 rats. This incidence of tumours was double that obtained with
approximately half the dose of cadmium (0-95 mg.) given as rat-ferritin and the
average induction time was very much shorter: only 13.3 months as compared with 21-6 months. From this comparison it would seem that as far as the induc-
tion of local tumours is concerned, the other constituents of ferritin had little
effect on carcinogenicity of cadmium.
In ni-ice a total dose of cadmium (as cadmium sulphate) approximately equi- valent, on a body weight basis, to that given to the rats (0-22 mg. as against
2-0 mg. for the rat) induced neither injection-site tumours nor testicular tumours
(Roe et al., 1964). The survival of the mice in this experiment was more satis-CADMIUM NEOPLASIA 671
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factory than in Experiment 11, and the negativity of the result can be accepted
with greater confidence.
in the experiments described, there was no indication that cadmium or
cadmium-precipitated ferritin led to the induction of tumours other than at the
site ofinjection and in the testis.
It is clear from the findings reported in this paper, and from those of others
(see introduction), that cadmium must be included in the list of metals known to
be capable of inducing cancer. This list now includes arsenic, beryflium, chro-
mium, cobalt, iron (as certain iron-carbohydrate complexes), lead, nickel and zinc
(see Roe and Lancaster, 1964, for review).
There appears at this stage to be a quahtative difference between the response
ofrats and mice to cadmiumsulphate in so far as noneoplasm hasyet been induced
in the latter species, either at the injection site or in the testis. It is possible,
however, that further experiments wiH prove this difference to be only a quantita-
tive one.
SUMMARY
Sarcomata arose at the site of repeated subcutaiieous injections of cadmium
sulphate or of cadmium-precipitated rat-ferritin in rats, but not in mice. The
incidence oftumours washigh (14 out of 20rats) in response to cadmiumsulphate,
and the presence of ferritin seemed to have little effect on tumour induction.
The testicular changes, namely, atrophy of seminiferous tubules, Leydig-cell hypeirplasia and Leydig-cell neoplasia, and the pituitary changes which also
occurred in response to cadmium treatment are described and discussed in an
accompanying paper (Roe et al., 1964).
There was no indication in these experiments that the administration of
cadmium orferritin increased the incidence ofneoplasms other than at theinjection site or in the testis.
We are grateful to Mr. J. L. Everett for preparing the ferritin used in Experi-
ments I and II and formeasuring the cadmium and water content ofthesample of
cadmium sulphate used in Experiments III and IV. Dur thanks are also due to
Alr. E. Woollard and Mr. K. Moreman and their staff for histological and photo- graphic assistance, respectively.
Thisinvestigation has beensupportedbygra'nts to theChesterBeatty Research
Institute (Institute ofCancer Research : Royal Can'cerHospital) from the Medical
Research Council. the BritishEmpire CancerCampaign for Research. the Tobacco
EXPLANATION OF PLATES
Fie.. I.-Spindle cell sarcoma arising in a rat at the site of the subcutaneous injection of
cadmium-precipitated rat-ferritin. The tumour appeared after 15 months. H. & E.
x 90.
FiG. 2.-Higher magnification ofFig. 1. H. & E. x 350.
Fie.. 3.-Spindle cell sarcoma arising in a rat at the site of subcutaneous injection of cadmium
sulphate. The tumour wa-s noticed after 15 months and had metastasised to the lung. H. & E. x90.
FIG. 4.-Higher magnification ofFig. 3. H. & E. x 350.
Fie.. 5.-Calcification at site of subcutaneous injection of cadn-iium sulphate in a rat. This
animal died during the 9th-month of the experiment. No neoplasm was found at the i'niec- tion site. H. & E. x25.BRITISH JOURNAL OF CANCER.
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